Annual Retained Earnings:
$498.98M-$4.03M(-0.80%)Summary
- As of today, LGND annual retained earnings is $498.98 million, with the most recent change of -$4.03 million (-0.80%) on December 31, 2024.
- During the last 3 years, LGND annual retained earnings has risen by +$49.89 million (+11.11%).
- LGND annual retained earnings is now -0.80% below its all-time high of $503.02 million, reached on December 31, 2023.
Performance
LGND Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
$461.38M+$4.85M(+1.06%)Summary
- As of today, LGND quarterly retained earnings is $461.38 million, with the most recent change of +$4.85 million (+1.06%) on June 30, 2025.
- Over the past year, LGND quarterly retained earnings has dropped by -$75.86 million (-14.12%).
- LGND quarterly retained earnings is now -21.69% below its all-time high of $589.15 million, reached on March 31, 2024.
Performance
LGND Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
LGND Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -0.8% | -14.1% |
| 3Y3 Years | +11.1% | -1.4% |
| 5Y5 Years | +24.7% | +17.4% |
LGND Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -0.8% | +11.1% | -21.7% | +2.3% |
| 5Y | 5-Year | -0.8% | +27.3% | -21.7% | +19.5% |
| All-Time | All-Time | -0.8% | +157.8% | -21.7% | +145.9% |
LGND Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $461.38M(+1.1%) |
| Mar 2025 | - | $456.53M(-8.5%) |
| Dec 2024 | $498.98M(-0.8%) | $498.98M(-5.9%) |
| Sep 2024 | - | $530.07M(-1.3%) |
| Jun 2024 | - | $537.24M(-8.8%) |
| Mar 2024 | - | $589.15M(+17.1%) |
| Dec 2023 | $503.02M(+11.6%) | $503.02M(+3.8%) |
| Sep 2023 | - | $484.83M(-2.1%) |
| Jun 2023 | - | $495.10M(+0.5%) |
| Mar 2023 | - | $492.81M(+9.3%) |
| Dec 2022 | $450.86M(+0.4%) | $450.86M(-3.7%) |
| Sep 2022 | - | $468.35M(+0.1%) |
| Jun 2022 | - | $467.94M(-0.2%) |
| Mar 2022 | - | $468.84M(+4.4%) |
| Dec 2021 | $449.09M(+14.6%) | $449.09M(-1.2%) |
| Sep 2021 | - | $454.51M(+3.1%) |
| Jun 2021 | - | $440.78M(+7.5%) |
| Mar 2021 | - | $410.06M(+4.6%) |
| Dec 2020 | $391.95M(-2.0%) | $391.95M(+1.5%) |
| Sep 2020 | - | $386.19M(-1.7%) |
| Jun 2020 | - | $392.89M(+6.0%) |
| Mar 2020 | - | $370.81M(-7.3%) |
| Dec 2019 | $400.11M(+274.6%) | $400.11M(-1.8%) |
| Sep 2019 | - | $407.47M(-3.6%) |
| Jun 2019 | - | $422.72M(-3.3%) |
| Mar 2019 | - | $437.14M(+290.7%) |
| Dec 2018 | -$229.20M(+42.8%) | -$229.20M(-24.6%) |
| Sep 2018 | - | -$183.91M(+27.7%) |
| Jun 2018 | - | -$254.24M(+22.3%) |
| Mar 2018 | - | -$327.40M(+18.3%) |
| Dec 2017 | -$400.92M(+7.0%) | -$400.92M(-1.8%) |
| Sep 2017 | - | -$393.91M(+2.1%) |
| Jun 2017 | - | -$402.34M(+1.5%) |
| Mar 2017 | - | -$408.40M(+5.3%) |
| Dec 2016 | -$431.13M(-0.4%) | -$431.13M(-0.7%) |
| Sep 2016 | - | -$428.00M(+0.2%) |
| Jun 2016 | - | -$429.05M(-1.5%) |
| Mar 2016 | - | -$422.88M(+1.5%) |
| Dec 2015 | -$429.49M(+34.9%) | -$429.49M(-4.6%) |
| Sep 2015 | - | -$410.46M(+35.4%) |
| Jun 2015 | - | -$635.00M(+3.6%) |
| Mar 2015 | - | -$658.56M(+0.1%) |
| Dec 2014 | -$659.32M(+1.8%) | -$659.32M(+1.1%) |
| Sep 2014 | - | -$666.37M(+0.2%) |
| Jun 2014 | - | -$667.65M(+0.2%) |
| Mar 2014 | - | -$669.24M(+0.3%) |
| Dec 2013 | -$671.34M(+1.7%) | -$671.34M(+0.3%) |
| Sep 2013 | - | -$673.21M(+0.3%) |
| Jun 2013 | - | -$675.17M(+0.9%) |
| Mar 2013 | - | -$681.26M(+0.2%) |
| Dec 2012 | -$682.76M(-0.1%) | -$682.76M(+0.2%) |
| Sep 2012 | - | -$683.82M(-0.2%) |
| Jun 2012 | - | -$682.65M(-0.3%) |
| Mar 2012 | - | -$680.39M(+0.3%) |
| Dec 2011 | -$682.23M(+1.4%) | -$682.23M(+0.7%) |
| Sep 2011 | - | -$687.27M(-0.6%) |
| Jun 2011 | - | -$682.84M(-0.1%) |
| Mar 2011 | - | -$681.92M(+1.4%) |
| Dec 2010 | -$691.95M(-1.5%) | -$691.95M(+0.6%) |
| Sep 2010 | - | -$696.45M(-1.7%) |
| Jun 2010 | - | -$684.61M(-0.0%) |
| Mar 2010 | - | -$684.33M(-0.4%) |
| Dec 2009 | -$681.57M | -$681.57M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | -$684.58M(+0.3%) |
| Jun 2009 | - | -$686.39M(-0.2%) |
| Mar 2009 | - | -$684.72M(-0.7%) |
| Dec 2008 | -$679.63M(-16.9%) | -$679.63M(-11.4%) |
| Sep 2008 | - | -$610.00M(-3.1%) |
| Jun 2008 | - | -$591.87M(-1.1%) |
| Mar 2008 | - | -$585.45M(-0.7%) |
| Dec 2007 | -$581.51M(+32.6%) | -$581.51M(+1.0%) |
| Sep 2007 | - | -$587.45M(+0.2%) |
| Jun 2007 | - | -$588.70M(+0.0%) |
| Mar 2007 | - | -$588.88M(+31.7%) |
| Dec 2006 | -$862.80M(-3.8%) | -$862.80M(+14.1%) |
| Sep 2006 | - | -$1.00B(-1.5%) |
| Jun 2006 | - | -$989.25M(-1.6%) |
| Mar 2006 | - | -$973.29M(-17.1%) |
| Dec 2005 | -$831.06M(-4.6%) | -$831.06M(-0.3%) |
| Sep 2005 | - | -$828.34M(-0.8%) |
| Jun 2005 | - | -$822.06M(-1.1%) |
| Mar 2005 | - | -$813.13M(-2.3%) |
| Dec 2004 | -$794.66M(-21.2%) | -$794.66M(-15.2%) |
| Sep 2004 | - | -$689.92M(-1.0%) |
| Jun 2004 | - | -$683.13M(-2.1%) |
| Mar 2004 | - | -$668.92M(-2.0%) |
| Dec 2003 | -$655.78M(-6.1%) | -$655.78M(+0.9%) |
| Sep 2003 | - | -$661.72M(-1.7%) |
| Jun 2003 | - | -$650.63M(-1.9%) |
| Mar 2003 | - | -$638.64M(-3.3%) |
| Dec 2002 | -$618.32M(-5.6%) | -$618.32M(-1.1%) |
| Sep 2002 | - | -$611.59M(-1.2%) |
| Jun 2002 | - | -$604.54M(-2.1%) |
| Mar 2002 | - | -$592.29M(-1.1%) |
| Dec 2001 | -$585.72M(-7.9%) | -$585.72M(-2.3%) |
| Sep 2001 | - | -$572.66M(-1.4%) |
| Jun 2001 | - | -$564.92M(-1.9%) |
| Mar 2001 | - | -$554.31M(-2.1%) |
| Dec 2000 | -$542.73M(-15.4%) | -$542.73M(-5.0%) |
| Sep 2000 | - | -$516.69M(-3.0%) |
| Jun 2000 | - | -$501.76M(-3.4%) |
| Mar 2000 | - | -$485.30M(-3.2%) |
| Dec 1999 | -$470.35M(-18.9%) | -$470.35M(-5.1%) |
| Sep 1999 | - | -$447.49M(-4.3%) |
| Jun 1999 | - | -$429.18M(-4.6%) |
| Mar 1999 | - | -$410.19M(-3.7%) |
| Dec 1998 | -$395.63M(-42.4%) | -$395.63M(-11.5%) |
| Sep 1998 | - | -$354.97M(-15.0%) |
| Jun 1998 | - | -$308.69M(-6.0%) |
| Mar 1998 | - | -$291.28M(-4.9%) |
| Dec 1997 | -$277.74M(-56.4%) | -$277.70M(-32.4%) |
| Sep 1997 | - | -$209.70M(-5.9%) |
| Jun 1997 | - | -$198.10M(-5.5%) |
| Mar 1997 | - | -$187.70M(-5.7%) |
| Dec 1996 | -$177.59M(-26.6%) | -$177.60M(-7.1%) |
| Sep 1996 | - | -$165.80M(-5.3%) |
| Jun 1996 | - | -$157.40M(-6.8%) |
| Mar 1996 | - | -$147.40M(-5.1%) |
| Dec 1995 | -$140.28M(-84.3%) | -$140.30M(-6.4%) |
| Sep 1995 | - | -$131.90M(-61.1%) |
| Mar 1995 | - | -$81.90M(-7.6%) |
| Dec 1994 | -$76.11M(-55.2%) | -$76.10M(-9.3%) |
| Sep 1994 | - | -$69.60M(-10.0%) |
| Jun 1994 | - | -$63.30M(-13.0%) |
| Mar 1994 | - | -$56.00M |
| Dec 1993 | -$49.03M(-65.8%) | - |
| Dec 1992 | -$29.57M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual retained earnings?
- What is the all-time high annual retained earnings for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual retained earnings?
The current annual retained earnings of LGND is $498.98M
What is the all-time high annual retained earnings for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual retained earnings is $503.02M
What is Ligand Pharmaceuticals Incorporated annual retained earnings year-on-year change?
Over the past year, LGND annual retained earnings has changed by -$4.03M (-0.80%)
What is Ligand Pharmaceuticals Incorporated quarterly retained earnings?
The current quarterly retained earnings of LGND is $461.38M
What is the all-time high quarterly retained earnings for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly retained earnings is $589.15M
What is Ligand Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
Over the past year, LGND quarterly retained earnings has changed by -$75.86M (-14.12%)